156 related articles for article (PubMed ID: 34703931)
1. Up-regulation of
Molaei Ramshe S; Ghaedi H; Omrani MD; Geranpayeh L; Alipour B; Ghafouri-Fard S
Heliyon; 2021 Oct; 7(10):e08179. PubMed ID: 34703931
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of vimentin and the related lncRNA network in breast cancer.
Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.
Dianatpour A; Faramarzi S; Geranpayeh L; Mirfakhraie R; Motevaseli E; Ghafouri-Fard S
Cancer Biomark; 2018; 22(1):49-54. PubMed ID: 29439313
[TBL] [Abstract][Full Text] [Related]
4. Expression Analysis of Long Non-Coding RNAs Related With FOXM1, GATA3, FOXA1 and ESR1 in Breast Tissues.
Hassani B; Taheri M; Asgari Y; Zekri A; Sattari A; Ghafouri-Fard S; Pouresmaeili F
Front Oncol; 2021; 11():671418. PubMed ID: 34094972
[TBL] [Abstract][Full Text] [Related]
5. Assessment of SGO1 and SGO1-AS1 contribution in breast cancer.
Nasim N; Ghafouri-Fard S; Soleimani S; Esfandi F; Shirkhoda M; Safaei M; Oskooei VK; Taheri M; Raheb J
Hum Antibodies; 2019; 27(4):279-284. PubMed ID: 31156154
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer.
Zarei M; Malekzadeh K; Omidi M; Mousavi P
Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469
[TBL] [Abstract][Full Text] [Related]
7. DSCAM-AS1 up-regulation in invasive ductal carcinoma of breast and assessment of its potential as a diagnostic biomarker.
Khorshidi H; Azari I; Oskooei VK; Taheri M; Ghafouri-Fard S
Breast Dis; 2019; 38(1):25-30. PubMed ID: 30594914
[TBL] [Abstract][Full Text] [Related]
8. Transcription Levels of nicotinamide nucleotide transhydrogenase and Its Antisense in Breast Cancer Samples.
Saleh Gargari S; Taheri M; Kholghi Oskooei V; Omrani MD; Ghafouri-Fard S
Cell J; 2019 Oct; 21(3):331-336. PubMed ID: 31210440
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
[TBL] [Abstract][Full Text] [Related]
10. Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer.
Yaghoobi H; Azizi H; Oskooei VK; Taheri M; Ghafouri-Fard S
World J Surg Oncol; 2018 Oct; 16(1):211. PubMed ID: 30336781
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
Ghafouri-Fard S; Taherian-Esfahani Z; Dashti S; Kholghi Oskooei V; Taheri M; Samsami M
Exp Mol Pathol; 2020 Jun; 114():104415. PubMed ID: 32165090
[TBL] [Abstract][Full Text] [Related]
12. GAS8 and GAS8-AS1 expression in gastric cancer.
Esfandi F; Mohammad Rezaei F; Taheri M; Naby Gol M; Kholghi Oskooei V; Namvar A; Ghafouri-Fard S
Gastroenterol Hepatol Bed Bench; 2019; 12(4):322-327. PubMed ID: 31749921
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of autophagy-related long non-coding RNAs in Iranian patients with breast cancer.
Safarzadeh A; Akhavan-Bahabadi M; Hussen BM; Nicknam A; Eslami S; Pouresmaeili F; Ghafouri-Fard S; Taheri M
Pathol Res Pract; 2022 Nov; 239():154146. PubMed ID: 36195025
[TBL] [Abstract][Full Text] [Related]
14. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
[TBL] [Abstract][Full Text] [Related]
15. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.
Torkashvand S; Basi A; Ajdarkosh H; Rakhshani N; Nafisi N; Mowla SJ; Moghadas A; Mohammadipour M; Karbalaie Niya MH
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2897-2902. PubMed ID: 34582659
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Arylsulfatase D (ARSD) and long noncoding RNA ARSD-AS1 gene expression in breast cancer patients and their association with oncogenic transcription factors.
Bahramian S; T Shamsabadi F; Fazel A; Delshad E; Amini A; Memari F; Shafiee M
J BUON; 2020; 25(4):1805-1813. PubMed ID: 33099917
[TBL] [Abstract][Full Text] [Related]
19. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
